Medtronic (NYSE: MDT) CAO has 148 shares withheld for taxes

Rhea-AI Filing Summary

Medtronic plc’s Chief Accounting Officer, Denise L. Blomquist, reported an automatic share withholding related to equity compensation. On 01/29/2026, 148 Ordinary Shares were withheld at $101 per share to cover taxes upon the vesting of previously reported restricted stock units.

After this tax withholding, Blomquist beneficially owns 12,306 Medtronic Ordinary Shares directly, which includes 97 shares acquired through dividend reinvestment since her last report.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blomquist Denise L.

(Last) (First) (Middle)

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MN 55432

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	01/29/2026		F		148(1)	D	$101	12,306(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

2. Includes 97 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Medtronic (MDT) report for Denise L. Blomquist?

Medtronic reported that Chief Accounting Officer Denise L. Blomquist had 148 Ordinary Shares withheld on 01/29/2026. The shares were withheld at $101 each to pay taxes due on vesting restricted stock units previously disclosed.

Was the Medtronic (MDT) insider transaction an open market sale?

No, the Medtronic transaction reflects shares withheld for taxes, not an open market sale. The 148 Ordinary Shares were retained by the company to satisfy tax obligations when restricted stock units vested for the executive.

How many Medtronic (MDT) shares does the Chief Accounting Officer now own?

After the 148-share tax withholding, Chief Accounting Officer Denise L. Blomquist beneficially owns 12,306 Medtronic Ordinary Shares directly. This total includes 97 shares that were acquired through dividend reinvestment since her prior insider ownership report.

What does the Form 4 footnote say about the Medtronic (MDT) tax withholding?

The footnote explains the 148 shares represent amounts withheld to pay taxes upon vesting of restricted stock units. These units were previously reported, and the withholding is a standard mechanism to cover income tax obligations for the equity award.

How were dividend reinvestments reported for Medtronic (MDT) insider Denise L. Blomquist?

The filing notes that her beneficial ownership figure includes 97 Ordinary Shares acquired through dividend reinvestment. These shares accumulated since the last report, increasing her direct holdings alongside the reported tax-withholding transaction.